Compound Screening

Various sublibraries from ICCB and FDA approved chemical compounds can be screened on the DMA 

Miniaturized Cell Assays

1-100 cells per experiment - suitable for primary, iPS or other rare cell types

Nano Dispensing 

Easily adaptable to different nano liquid dispensers to perform powerful cell screenings

 
 

THE DROPLET MICROARRAY (DMA) TECHNOLOGY:

The Droplet Microarray (DMA) is Aquarray’s patented technology for cell cultivation, high throughput screening (HTS) and biochemical assay platforms. The DMA delivers the potential of microarray technologies to the field of cell based screening systems. Aquarray opens multiplexing opportunities to research areas all the way from basic research over industrial HTS to clinical applications.


Aquarray Drug Discovery

In a freshly developed approach, Aquarray combines the main components of Drug Discovery on a single platform.
Within days a unique library of new compounds can be synthesized, analyzed, and tested in a primary screening on cells on a single DMA slide.
 
 

Always First.

Be the first to find out all the latest news, products, and trends.